<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01560702</url>
  </required_header>
  <id_info>
    <org_study_id>IRB#:278/12-3-2012</org_study_id>
    <nct_id>NCT01560702</nct_id>
  </id_info>
  <brief_title>Comparative Study of Autologous Blood Injection Versus Diluted Epinephrine in Treating Actively Bleeding Gastroduodenal Ulcers</brief_title>
  <official_title>Endoscopic Injection of Autologous Blood Versus Diluted Epinephrine for Control of Actively Bleeding Gastroduodenal Ulcers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zagazig University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zagazig University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endoscopic injection of autologous blood can control bleeding from gastroduodenal ulcers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To test the hypothesis that endoscopic injection of autologous blood is superior to
      endoscopic injection of diluted epinephrine in controlling bleeding from gastroduodenal
      ulcers.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>hemostasis from the ulcer after injection and/or stoppage of haematemesis and melena one day after the procedure.</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>development of re-bleeding after 24 hours after the procedure (occurrence of hematemesis or melena or drop of hemoglobin level &gt;2gm/dl).</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Blood, Injection, Injury Type Phobia</condition>
  <condition>Gastrointestinal Ulcer Haemorrhage</condition>
  <condition>Adverse Reaction to Epinephrine</condition>
  <arm_group>
    <arm_group_label>Autologous blood</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be injected by autologous blood at the edge of actively bleeding ulcer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epinephrine injection</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients will be injected by diluted epinephrine at the edge of actively bleeding ulcer</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epinephrine</intervention_name>
    <description>10-30 cc of 1/10000 diluted epinephrine will be injected at edges of an actively bleeding ulcer.</description>
    <arm_group_label>Epinephrine injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood</intervention_name>
    <description>5-20 cc autologous blood immediately withdrawn from the patient will be injected at edges of the actively bleeding ulcer.</description>
    <arm_group_label>Autologous blood</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all adult patients with gastroduodenal ulcer

        Exclusion Criteria:

          -  Patients with non ulcer bleeding.

          -  Patients with malignancy.

          -  Patients with bleeding disorders or under coagulation therapy.

          -  Patients with known allergy to epinephrine.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed H Emara, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tropical Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, 44519, Egypt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zagazig University Hospitals</name>
      <address>
        <city>Zagazig</city>
        <state>Sharkia</state>
        <zip>44519</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <link>
    <url>http://mis.zu.edu.eg/ajied/home.aspx</url>
    <description>Our Department official journal</description>
  </link>
  <link>
    <url>http://www.zu.edu.eg/</url>
    <description>Our home institution</description>
  </link>
  <link>
    <url>http://www.hosp.zu.edu.eg/</url>
    <description>Our Hospital</description>
  </link>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 20, 2012</study_first_submitted>
  <study_first_submitted_qc>March 21, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2012</study_first_posted>
  <last_update_submitted>September 24, 2013</last_update_submitted>
  <last_update_submitted_qc>September 24, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zagazig University</investigator_affiliation>
    <investigator_full_name>Moahmed Hassan Emara</investigator_full_name>
    <investigator_title>Lecturer</investigator_title>
  </responsible_party>
  <keyword>autologous blood</keyword>
  <keyword>epinephrine</keyword>
  <keyword>endoscopy</keyword>
  <keyword>ulcer</keyword>
  <keyword>hemostasis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Peptic Ulcer</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

